» Articles » PMID: 22865929

ERα Phosphorylation at Y537 by Src Triggers E6-AP-ERα Binding, ERα Ubiquitylation, Promoter Occupancy, and Target Gene Expression

Overview
Journal Mol Endocrinol
Date 2012 Aug 7
PMID 22865929
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Many transcription factors undergo transcription-coupled proteolysis. Although ligand binding activates ubiquitin proteolysis of estrogen receptor α (ERα), mechanisms governing this and its relationship to transcriptional activation were unclear. Data presented link cross talk between the Src kinase and liganded ERα with ERα activation and its ubiquitylation. Liganded ERα rapidly activates and recruits Src, which phosphorylates ERα at tyrosine 537 (Y537). This enhances ERα binding to the ubiquitin ligase/ERα coactivator, E6-associated protein (E6-AP), stimulating ERα ubiquitylation, target gene activation, and ultimately ERα loss. ERα phosphorylation by Src promotes ERα ubiquitylation by E6-AP and proteasomal degradation in vitro. Src inhibition impairs estrogen (E2)-activated ERα:E6-AP binding, reducing ERα degradation. ERα-Y537F shows little E2-stimulated degradation and activates native ERα target genes poorly. Src activation enhances ERα and E6-AP binding and their occupancy at ERα target gene promoters to enhance transcription. Thus, ERαY537 phosphorylation drives ERα:E6-AP binding to at least a subset of target promoters, linking transcriptional activation to ERα degradation and providing a novel mechanism to fine tune ERα action. The observation that ERα transcriptional activity can be briskly maintained in a context of reduced ERα levels raises the possibility that hormonally sensitive tissues may not always show robust ERα protein levels.

Citing Articles

Context-Dependent Estrogenic Actions of (+)-Pisatin Produced in Elicited Green or Snow Pea ().

Belgodere J, Benz M, Kpeli G, Elliott J, Elliott S, North J J Agric Food Chem. 2024; 72(51):28255-28269.

PMID: 39665386 PMC: 11674159. DOI: 10.1021/acs.jafc.4c06409.


Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes.

Sereda E, Kolegova E, Kakurina G, Korshunov D, Sidenko E, Doroshenko A Transl Breast Cancer Res. 2024; 3:23.

PMID: 38751528 PMC: 11093047. DOI: 10.21037/tbcr-22-22.


TRIM33 Is a Co-Regulator of Estrogen Receptor Alpha.

Romo B, Karakyriakou B, Cressey L, Brauer B, Yang H, Warren A Cancers (Basel). 2024; 16(5).

PMID: 38473207 PMC: 10930732. DOI: 10.3390/cancers16050845.


Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression.

Nandi I, Smith H, Sanguin-Gendreau V, Ji L, Pacis A, Papavasiliou V J Clin Invest. 2023; 133(7).

PMID: 36795481 PMC: 10065076. DOI: 10.1172/JCI162324.


Estrogen signaling via estrogen receptor alpha and its implications for neurodegeneration associated with Alzheimer's disease in aging women.

Tecalco-Cruz A, Lopez-Canovas L, Azuara-Liceaga E Metab Brain Dis. 2023; 38(3):783-793.

PMID: 36640216 DOI: 10.1007/s11011-023-01161-2.


References
1.
Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos M . BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science. 1999; 284(5418):1354-6. DOI: 10.1126/science.284.5418.1354. View

2.
Cardozo T, Pagano M . The SCF ubiquitin ligase: insights into a molecular machine. Nat Rev Mol Cell Biol. 2004; 5(9):739-51. DOI: 10.1038/nrm1471. View

3.
He M, Mangiameli D, Kachala S, Hunter K, Gillespie J, Bian X . Expression signature developed from a complex series of mouse models accurately predicts human breast cancer survival. Clin Cancer Res. 2009; 16(1):249-59. PMC: 2866744. DOI: 10.1158/1078-0432.CCR-09-1602. View

4.
Aronica S, Kraus W, Katzenellenbogen B . Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci U S A. 1994; 91(18):8517-21. PMC: 44637. DOI: 10.1073/pnas.91.18.8517. View

5.
Sun J, Nawaz Z, Slingerland J . Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol Endocrinol. 2007; 21(11):2651-62. DOI: 10.1210/me.2007-0082. View